Cargando…
Synergy between liposomal zoledronic acid and γδ T-cells in the treatment of epithelial ovarian cancer
Autores principales: | Pereira, Ana Catarina Parente, Shmeeda, Hilary, Whilding, Lynsey, Ghaem-Maghami, Sadaf, Gabizon, Alberto, Maher, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991067/ http://dx.doi.org/10.1186/2051-1426-1-S1-P28 |
Ejemplares similares
-
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer
por: Wahba, John, et al.
Publicado: (2018) -
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
por: Gabizon, Alberto, et al.
Publicado: (2023) -
In Vivo PET Tracking of (89)Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal Alendronate
por: Man, Francis, et al.
Publicado: (2019) -
Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy
por: Gabizon, Alberto, et al.
Publicado: (2021) -
Is ovarian cancer surgery stuck in the dark ages?: a commentary piece reviewing surgical technologies
por: Phelps, David L., et al.
Publicado: (2020)